US 7214787
Recombinant vaccine against botulinum neurotoxin
granted A61KA61K39/00A61K39/08
Quick answer
US patent 7214787 (Recombinant vaccine against botulinum neurotoxin) held by The United States of America as represented by the Secretary of the Army expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K39/00, A61K39/08